Khan Najat 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Khan Najat
DirectorCEO and President
Transactions
- Tax Payment
Class A Common Stock
2025-11-17$4.14/sh−17,584$72,798→ 735,538 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.